Literature DB >> 25097213

Atherosclerotic cardiovascular disease prevention: a comparison between the third adult treatment panel and the new 2013 Treatment of Blood Cholesterol Guidelines.

Andre R M Paixao1, Colby R Ayers1, Jarett D Berry1, James A de Lemos1, Amit Khera2.   

Abstract

Entities:  

Keywords:  cardiovascular diseases; cholesterol

Mesh:

Substances:

Year:  2014        PMID: 25097213      PMCID: PMC4167934          DOI: 10.1161/CIRCOUTCOMES.114.001139

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


× No keyword cloud information.
  6 in total

1.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

2.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

Review 3.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

Review 4.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

5.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

Authors:  Ronald G Victor; Robert W Haley; DuWayne L Willett; Ronald M Peshock; Patrice C Vaeth; David Leonard; Mujeeb Basit; Richard S Cooper; Vincent G Iannacchione; Wendy A Visscher; Jennifer M Staab; Helen H Hobbs
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

6.  Application of new cholesterol guidelines to a population-based sample.

Authors:  Michael J Pencina; Ann Marie Navar-Boggan; Ralph B D'Agostino; Ken Williams; Benjamin Neely; Allan D Sniderman; Eric D Peterson
Journal:  N Engl J Med       Date:  2014-03-19       Impact factor: 91.245

  6 in total
  7 in total

1.  Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.

Authors:  Amit Pursnani; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; Udo Hoffmann
Journal:  JAMA       Date:  2015-07-14       Impact factor: 56.272

Review 2.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

Review 3.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

Authors:  Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff
Journal:  Circulation       Date:  2016-11-04       Impact factor: 29.690

4.  Clinical Criteria to Identify Patients With Sepsis.

Authors:  Anil N Makam; Oanh Kieu Nguyen
Journal:  JAMA       Date:  2016-07-26       Impact factor: 56.272

5.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

Authors:  Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff
Journal:  J Am Coll Cardiol       Date:  2016-11-04       Impact factor: 24.094

6.  Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats Remain.

Authors:  Neil J Stone
Journal:  J Am Heart Assoc       Date:  2016-08-19       Impact factor: 5.501

7.  Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.

Authors:  Ehimare Akhabue; Sarah S Rittner; Joseph E Carroll; Phillip M Crawford; Lydia Dant; Reesa Laws; Michael C Leo; Jon Puro; Stephen D Persell
Journal:  J Am Heart Assoc       Date:  2017-07-03       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.